STAT3 and diabetes mellitus: Taken together, these key findings suggest that miR-221-3p may directly inhibit the expression of DYRK1A to regulate the inflammatory response of epithelial tissues mediated by the STAT3 signaling pathway and thus promote skin wound healing in diabetes (Fig. 10).